[1]
F. Ferrara and A. Vitiello, “Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients”, Ital J Med, vol. 15, no. 1, Dec. 2020.